These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 18445737)

  • 21. Elevated levels of measles antibodies in children with autism.
    Singh VK; Jensen RL
    Pediatr Neurol; 2003 Apr; 28(4):292-4. PubMed ID: 12849883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Practices for Measles-Mumps-Rubella Vaccination Among US Pediatric International Travelers.
    Hyle EP; Rao SR; Bangs AC; Gastañaduy P; Fiebelkorn AP; Hagmann SHF; Walker AT; Walensky RP; Ryan ET; LaRocque RC
    JAMA Pediatr; 2020 Feb; 174(2):e194515. PubMed ID: 31816033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccines for measles, mumps and rubella in children.
    Demicheli V; Jefferson T; Rivetti A; Price D
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004407. PubMed ID: 16235361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology.
    Smeeth L; Hall AJ; Fombonne E; Rodrigues LC; Huang X; Smith PG
    BMC Public Health; 2001; 1():2. PubMed ID: 11231881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Measles, mumps and rubella vaccination status of school beginners in Munich].
    Markuzzi A; Schlipköter U; Weitkunat R; Meyer G
    Soz Praventivmed; 1997; 42(3):133-43. PubMed ID: 9334085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in India: A randomized, parallel group, non-inferiority trial.
    Bavdekar A; Oswal J; Ramanan PV; Aundhkar C; Venugopal P; Kapse D; Miller T; McGray S; Zehrung D; Kulkarni PS;
    Vaccine; 2018 Feb; 36(9):1220-1226. PubMed ID: 29395526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up.
    Carryn S; Feyssaguet M; Povey M; Di Paolo E
    Vaccine; 2019 Aug; 37(36):5323-5331. PubMed ID: 31345639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study.
    Hviid A; Hansen JV; Frisch M; Melbye M
    Ann Intern Med; 2019 Apr; 170(8):513-520. PubMed ID: 30831578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.
    Leung JH; Hirai HW; Tsoi KK
    Expert Rev Vaccines; 2015; 14(8):1149-57. PubMed ID: 26081133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles, mumps, and rubella vaccination and autism.
    Mullins ME
    N Engl J Med; 2003 Mar; 348(10):951-4; author reply 951-4. PubMed ID: 12622122
    [No Abstract]   [Full Text] [Related]  

  • 32. Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.
    Feiterna-Sperling C; Brönnimann R; Tischer A; Stettler P; Durrer P; Gaedicke G
    Pediatr Infect Dis J; 2005 Dec; 24(12):1083-8. PubMed ID: 16371870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.
    Nolan T; McIntyre P; Roberton D; Descamps D
    Vaccine; 2002 Dec; 21(3-4):281-9. PubMed ID: 12450703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccines and autism.
    DeStefano F
    Pediatr Infect Dis J; 2001 Sep; 20(9):887-8. PubMed ID: 11734770
    [No Abstract]   [Full Text] [Related]  

  • 35. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles-mumps-rubella vaccine and the development of autism.
    Miller E
    Semin Pediatr Infect Dis; 2003 Jul; 14(3):199-206. PubMed ID: 12913832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M; Christenson B; Strandell A; Romanus V
    Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan atlanta.
    DeStefano F; Bhasin TK; Thompson WW; Yeargin-Allsopp M; Boyle C
    Pediatrics; 2004 Feb; 113(2):259-66. PubMed ID: 14754936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children.
    France EK; Glanz J; Xu S; Hambidge S; Yamasaki K; Black SB; Marcy M; Mullooly JP; Jackson LA; Nordin J; Belongia EA; Hohman K; Chen RT; Davis R;
    Pediatrics; 2008 Mar; 121(3):e687-92. PubMed ID: 18310189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine.
    LeBaron CW; Bi D; Sullivan BJ; Beck C; Gargiullo P
    Pediatrics; 2006 Oct; 118(4):1422-30. PubMed ID: 17015532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.